MCLAREN BAY SPECIAL CARE
1. Target Overview & Investment Thesis
MCLAREN BAY SPECIAL CARE is a 15-bed suburban community hospital in BAY, MI with $7.2M in net patient revenue and a 16.9% operating margin. The hospital serves a payer mix of 58.1% Medicare, 0.7% Medicaid, and 41.2% commercial.
Thesis: Turnaround. Our ML models identify $538K in annual EBITDA improvement potential from RCM optimization across 5 levers, lifting margin from 16.9% to 24.4% (+749bps).
| Net Revenue HCRIS | $7.2M |
| Current EBITDA COMPUTED | $1.2M |
| Operating Margin COMPUTED | 16.9% |
| Occupancy HCRIS | 73.6% |
| Revenue / Bed COMPUTED | $479K |
| Net-to-Gross HCRIS | 34.6% |
| Distress Probability ML | 44.4% |
2. Market Context & Competitive Position
MI has 163 Medicare-certified hospitals with a median operating margin of -5.2%. The target's margin of 16.9% places it above the state median. Among 44 size-comparable peers (8-30 beds), the median margin is 1.1%. The target performs in line with or above peers.
3. RCM Performance Analysis — Comparable Hospitals
Comps selected by bed count (8-30), prioritizing same-state peers. 44 hospitals in the comp set.
| Hospital | State | Beds | Revenue | Margin |
|---|---|---|---|---|
| MCLAREN BAY SPECIAL CARE (Target) | MI | 15 | $7.2M | 16.9% |
| SPECTRUM HEALTH GERBER | MI | 25 | $116.2M | 16.0% |
| ST. FRANCIS HOSPITAL | MI | 25 | $106.2M | 7.8% |
| SPECTRUM HEALTH PENNOCK HOSPIT | MI | 25 | $96.5M | 11.1% |
| SPECTRUM HEALTH REED CITY | MI | 25 | $77.1M | 21.2% |
| SPARROW EATON | MI | 25 | $76.1M | 11.5% |
| MUNSON HEALTHCARE CHARLEVOIX H | MI | 25 | $73.6M | 1.9% |
| BRONSON LAKEVIEW HOSPITAL | MI | 16 | $67.9M | 14.6% |
| ASPIRUS IRONWOOD HOSPITAL | MI | 25 | $65.4M | -3.5% |
4. Predicted Improvement Opportunities
Improvement targets set at P75 of comparable peers with 60% gap closure assumption. Coefficients calibrated to published research bands. Total EBITDA uplift: $538K (749bps margin improvement).
| Lever | Current | Target | EBITDA Impact | Margin | Ramp |
|---|---|---|---|---|---|
| Net Collection Rate | 93.5% | 97.0% | $151K | +210bp | 18mo |
| Denial Rate Reduction | 12.0% | 6.5% | $146K | +204bp | 12mo |
| Cost to Collect | 4.5% | 2.5% | $144K | +200bp | 12mo |
| A/R Days Reduction | 5200.0% | 3800.0% | $87K | +122bp | 9mo |
| Clean Claim Rate | 88.0% | 96.0% | $10K | +13bp | 6mo |
5. EBITDA Bridge
| Current EBITDA | $1.2M |
| + RCM Uplift | +$538K |
| Pro Forma EBITDA | $1.8M |
| Current Margin | 16.9% |
| Pro Forma Margin | 24.4% |
| WC Released (1x) | $275K |
6. Returns Analysis — Scenario Matrix
5-year hold, 5.5x leverage, 3% organic growth, 10%/yr debt paydown. Base case uses 100% of predicted RCM uplift. Bull case: 130% uplift at lower entry. Bear case: 50% uplift at higher entry.
| Scenario | Entry | Exit | Equity In | Equity Out | MOIC | IRR |
|---|---|---|---|---|---|---|
| Base Case | 10.0x | 10.0x | $1.9M | $13.4M | 7.17x | 48.3% |
| Base (11x exit) | 10.0x | 11.0x | $1.9M | $15.3M | 8.21x | 52.3% |
| Bull Case | 9.0x | 11.0x | $1.7M | $17.7M | 10.54x | 60.2% |
| Bull (12x exit) | 9.0x | 12.0x | $1.7M | $19.8M | 11.79x | 63.8% |
| Bear Case | 11.0x | 10.0x | $2.1M | $10.1M | 4.91x | 37.5% |
| Bear (11x exit) | 11.0x | 11.0x | $2.1M | $11.8M | 5.73x | 41.8% |
7. Key Risks & Mitigants
| Severity | Risk Factor | Mitigant |
|---|---|---|
| Medium | Heavy Medicare dependence | Medicare comprises 58.1% of days; rate updates may lag inflation. Mitigant: CDI/CMI lever directly increases Medicare reimbursement |
8. Data Sources & Methodology Appendix
Data Sources
- CMS HCRIS Cost Reports (Medicare-certified hospitals)
- CMS Medicare Utilization (DRG-level volumes)
- CMS Chronic Conditions (county-level disease prevalence)
- HCRIS multi-year trend data (financial time series)
Comparable Selection
- 44 hospitals with 8-30 beds
- Same-state prioritization (n=48)
- Comp margins: P25=-9.8% / P50=1.1% / P75=9.2%
Bridge Methodology
- Targets: P75 of comparable peers (60% gap closure)
- Denial: avoidable share = 35% of delta × NPR
- AR: bad debt coefficient = $0.65 per day per $1K NPR
- NCR: 60% coefficient on collection rate improvement
- CDI: 0.75% of Medicare revenue per 0.01 CMI point
Returns Assumptions
- Leverage: 5.5x entry (84.6% debt / 15.4% equity)
- Organic growth: 3% annual EBITDA growth
- Debt paydown: 10% of principal per year
- Hold period: 5 years
Generated by SeekingChartis on April 26, 2026. All predictions use public data only. Confidence intervals calibrated via split conformal prediction (90% coverage target). This memo is for informational purposes and does not constitute investment advice.